General Biometrics Inc

FDA Filings

This page includes the latest FDA filings for General Biometrics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)

FDA Filings

Device
Company
DeviceDate
GENERAL BIOMETRICS, INC.
IMMUNODOT(R) ENA/DNA AUTOIMMUNITY SCREENING PANEL1992-12-01
GENERAL BIOMETRICS, INC.
IMMUNOWELL CARDIOLIPIN ANTIBODY (IGM) TEST1992-08-20
GENERAL BIOMETRICS, INC.
IMMUNOWELL CARDIOLIPIN ANTIBODY (IGG) TEST1992-08-20
GENERAL BIOMETRICS, INC.
IMMUNODOT BORRELIA (LYME) TEST1992-04-08
GENERAL BIOMETRICS, INC.
IMMUNOWELL LYME (P39 RECOMBINANT) TEST1991-12-30
GENERAL BIOMETRICS, INC.
IMMUNOWELL BORRELIA (LYME)TEST1991-12-20
GENERAL BIOMETRICS, INC.
IMMUNOWELL DSDNA ANTIBODY TEST1991-12-09
GENERAL BIOMETRICS, INC.
IMMUNOWELL SM ANTIBODY TEST1991-05-07
GENERAL BIOMETRICS, INC.
IMMUNWELL SJOGREN`S SYNDROME B (LA) ANTIBODY TEST1991-05-07
GENERAL BIOMETRICS, INC.
IMMUNOWELL SJOGRENS SYNDROME A (RO)ANTIBODY TEST1991-05-07
GENERAL BIOMETRICS, INC.
IMMUNOWELL RNP/SM ANTIBODY TEST1991-05-07
GENERAL BIOMETRICS, INC.
IMMUNOWELL THYROGLOBULIN TEST1991-01-25
GENERAL BIOMETRICS, INC.
IMMUNOWELL TPO (MICROSOME) TEST1991-01-03
GENERAL BIOMETRICS, INC.
IMMUNODOT THYROID AUTOIMMUNITY PANEL1990-10-02
GENERAL BIOMETRICS, INC.
IMMUMODOT AUTOIMMUNITY SCREENING PANEL 41990-08-09
GENERAL BIOMETRICS, INC.
IMMUNODOT AUTOIMMUNITY SCREENING PANEL 31990-08-09
GENERAL BIOMETRICS, INC.
IMMUNODOT AUTOIMMUNITY SCREENING PANEL 21990-01-24
GENERAL BIOMETRICS, INC.
IMMUNODOT AUTOIMMUNE SCREENING PANEL 11989-12-05
GENERAL BIOMETRICS, INC.
IMMUNODOT LYME TEST1989-10-30
GENERAL BIOMETRICS, INC.
IMMUNODOT RUBELLA TEST1989-10-16
GENERAL BIOMETRICS, INC.
IMMUNODOT INFECTIOUS MONONUCLEOSIS TEST1989-09-13
GENERAL BIOMETRICS, INC.
IMMUNODOT TORCH TEST RUBELLA1989-02-03
GENERAL BIOMETRICS, INC.
IMMUNODOT RUBELLA TEST1989-02-02

Related Finance Registrations

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.